It was not until the 1990s that the tyrosine kinase receptor Kit (c-Kit), also known as CD117 or the stem cell factor receptor, was identified as the primary marker for ICC in pathological specimens (2, 3). The gene discussed is KIT; the disease is intrahepatic cholangiocarcinoma.